Follicum
Today, Follicum announced their phase 2a trial of FOL-005 for the scalp is fully recruited. The trial consists of injections of Follicum’s modified peptide, FOL-005, over a three month period. This trial design is supportive for a data readout by year’s end, as enrollment has been completed while still in June. CEO of Follicum, Jan…
Read MoreToday, there have been updates from two companies with therapies in phase 2 clinical trials for AGA. Initially, I posted the Follicum news to the Updates page, then I later found that Aclaris had released news as well. This was compelling enough to create an article for these news items. Follicum Trial Over 50% Enrolled…
Read More
An interesting bit of news was released by the company Follicum this morning. In conjunction with a specialized research company Dualsystems Biotech, Follicum has identified receptors in hair follicle cells that their lead drug candidate FOL-005 binds to. This represents a viable mechanism of action for their product. The press release mentions this information could…
Read More
Gunnar Gardemyr of Follicum recently reached out to Follicle Thought to share some messages with its readers regarding the progress of Follicum and details on what the company is looking forward to next year. Follicum is casually strolling into a major pivotal position in the hair growth industry and also has in the works some new…
Read MoreTwo days ago, I received an email from one of my readers which informed me that Follicum had just made an announcement about important developments that would be of interest to me. Upon further investigation, I found the Follicum website (only on the “Swedish” content) had put out a press release pertaining to the results…
Read MoreHello Everybody, I hope you all enjoy this edition of Weekly Thoughts which contains exciting news about the Tsuji Lab and a new nano-coating technology for stem cells. Tsuji Backed By Major Partner Dr. Takashi Tsuji of the Riken Research Institute has found a sponsor for his potential game changing hair growth research. Meiji Seika…
Read MoreHere we are in a new year which is always a good thing for technological advancements. I’m going to get right into things here with a look at the hair technology happenings I am most looking forward to in 2016: 1. Samumed’s Phase II efficacy results. Samumed has probably had the smoothest development progress of…
Read MoreThe Holiday season is in full swing, and there is a lot to be happy about in the world of hair regeneration. For starters, Histogen and Replicel should both be available within about two years time. See previous post for expanded info. Also in this issue, I’m really excited about the new patents Angela Christiano…
Read More
Angela Christiano is up to it again, and the online hair world is very thankful. It was just a little over a year ago when the internet was ablaze with the news that Dr. Angela Christiano and her colleagues were studying the pharmaceutical drug ruxolitinib in cases of alopecia areata. Like tofacitinib, ruxolitinib is a…
Read MoreCheers Everybody, It’s nice to be back here with you. Man, I do wish that hair regeneration news came more frequently, but I am happy to finally have some pertinent information to report upon. Wound Healing Company Interested in Hair Regeneration MicroCures, a biotech startup that is developing a siRNA technology for wound healing, has…
Read More- « Previous
- 1
- 2
- 3
- Next »